OSPET Completes Paid-In Capital Increase... Strengthens Financial Structure

OSPET has completed the payment for its additional paid-in capital increase.

According to OSPET on the 13th, the company has completely dispelled concerns in the market regarding funding and maintaining its listing. Based on the financial stability it has secured, OSPET will accelerate the implementation of its corporate value enhancement strategy.

With the positive momentum from the Korea-Canada quarantine agreement and participation in a U.S. trade show, OSPET is set to actively target the North American pet food market, which is estimated at 100 trillion won. Building on its track record in Latin America (Chile) and Asian markets, the company plans to significantly expand into North America, the world's largest market.

OSPET will participate in 'SuperZoo 2026,' the world’s largest pet industry trade show held in the U.S. this month, to actively secure distribution networks and engage in buyer negotiations. In particular, its proprietary brand 'Natural Signature,' which uses USDA-certified organic ingredients and boasts high palatability and safety, is expected to receive favorable reviews from local buyers.

The company will also continue to focus on strengthening its technological competitiveness and diversifying its business portfolio. By integrating the 47 years of expertise in veterinary medicine, pharmaceuticals, and bio R&D technology possessed by its parent company Woojin B&G with OSPET’s organic production infrastructure, the group aims to develop high value-added prescription feeds and create synergy between affiliates, thereby enhancing its technological differentiation.

An OSPET official stated, "The completion of this paid-in capital increase will secure financial stability and serve as an opportunity to accelerate our global market expansion," adding, "We will actively promote our premium manufacturing technology at the SuperZoo trade show in the United States and strive to achieve tangible export results."

This content was produced with the assistance of AI translation services.